• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者肝活检组织病理特征的观察者间一致性

Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease.

作者信息

Jung Eun Sun, Lee Kyoungbun, Yu Eunsil, Kang Yun Kyung, Cho Mee-Yon, Kim Joon Mee, Moon Woo Sung, Jeong Jin Sook, Park Cheol Keun, Park Jae-Bok, Kang Dae Young, Sohn Jin Hee, Jin So-Young

机构信息

Gastrointestinal Pathology Study Group of Korean Society of Pathologist, Seoul, Korea.

Department of Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

J Pathol Transl Med. 2016 May;50(3):190-6. doi: 10.4132/jptm.2016.03.01. Epub 2016 Apr 18.

DOI:10.4132/jptm.2016.03.01
PMID:27086596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4876083/
Abstract

BACKGROUND

The histomorphologic criteria for the pathological features of liver tissue from patients with non-alcoholic fatty liver disease (NAFLD) remain subjective, causing confusion among pathologists and clinicians. In this report, we studied interobserver agreement of NAFLD pathologic features and analyzed causes of disagreement.

METHODS

Thirty-one cases of clinicopathologically diagnosed NAFLD from 10 hospitals were selected. One hematoxylin and eosin and one Masson's trichrome-stained virtual slide from each case were blindly reviewed with regard to 12 histological parameters by 13 pathologists in a gastrointestinal study group of the Korean Society of Pathologists. After the first review, we analyzed the causes of disagreement and defined detailed morphological criteria. The glass slides from each case were reviewed a second time after a consensus meeting. The degree of interobserver agreement was determined by multi-rater kappa statistics.

RESULTS

Kappa values of the first review ranged from 0.0091-0.7618. Acidophilic bodies (k = 0.7618) and portal inflammation (k = 0.5914) showed high levels of agreement, whereas microgranuloma (k = 0.0984) and microvesicular fatty change (k = 0.0091) showed low levels of agreement. After the second review, the kappa values of the four major pathological features increased from 0.3830 to 0.5638 for steatosis grade, from 0.1398 to 0.2815 for lobular inflammation, from 0.1923 to 0.3362 for ballooning degeneration, and from 0.3303 to 0.4664 for fibrosis.

CONCLUSIONS

More detailed histomorphological criteria must be defined for correct diagnosis and high interobserver agreement of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)患者肝组织病理特征的组织形态学标准仍具有主观性,这在病理学家和临床医生中造成了困惑。在本报告中,我们研究了NAFLD病理特征的观察者间一致性,并分析了不一致的原因。

方法

从10家医院选取31例经临床病理诊断为NAFLD的病例。韩国病理学家协会胃肠研究组的13名病理学家对每个病例的一张苏木精-伊红染色和一张马松三色染色虚拟切片进行了盲法评估,涉及12个组织学参数。首次评估后,我们分析了不一致的原因并确定了详细的形态学标准。在一次共识会议后,对每个病例的玻片进行了第二次评估。观察者间一致性程度通过多评分者kappa统计量确定。

结果

首次评估的kappa值范围为0.0091 - 0.7618。嗜酸性小体(k = 0.7618)和门管区炎症(k = 0.5914)显示出较高的一致性,而微肉芽肿(k = 0.0984)和微泡性脂肪变(k = 0.0091)显示出较低的一致性。第二次评估后,四项主要病理特征的kappa值分别为:脂肪变性分级从0.3830增至0.5638,小叶炎症从0.1398增至0.2815,气球样变性从0.1923增至0.3362,纤维化从0.3303增至0.4664。

结论

必须定义更详细的组织形态学标准,以实现NAFLD的正确诊断和较高的观察者间一致性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/8938d664f0df/jptm-2016-03-01f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/50ddf60c18d6/jptm-2016-03-01f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/705265714a18/jptm-2016-03-01f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/5fbf8b2f5315/jptm-2016-03-01f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/5015c081324d/jptm-2016-03-01f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/d58dc89a755d/jptm-2016-03-01f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/8938d664f0df/jptm-2016-03-01f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/50ddf60c18d6/jptm-2016-03-01f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/705265714a18/jptm-2016-03-01f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/5fbf8b2f5315/jptm-2016-03-01f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/5015c081324d/jptm-2016-03-01f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/d58dc89a755d/jptm-2016-03-01f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c549/4876083/8938d664f0df/jptm-2016-03-01f6.jpg

相似文献

1
Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者肝活检组织病理特征的观察者间一致性
J Pathol Transl Med. 2016 May;50(3):190-6. doi: 10.4132/jptm.2016.03.01. Epub 2016 Apr 18.
2
Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.非酒精性脂肪性肝病:病理诊断变异性评估
Mod Pathol. 1998 Jun;11(6):560-5.
3
Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology.干预措施对非酒精性脂肪性肝病组织学解读的观察者内和观察者间一致性的影响。
Ann Diagn Pathol. 2011 Feb;15(1):19-24. doi: 10.1016/j.anndiagpath.2010.08.001. Epub 2010 Nov 24.
4
Interobserver Variability in Scoring Liver Biopsies with a Diagnosis of Alcoholic Hepatitis.酒精性肝炎肝活检评分的观察者间变异性。
Alcohol Clin Exp Res. 2017 Sep;41(9):1568-1573. doi: 10.1111/acer.13438. Epub 2017 Jul 28.
5
A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy.一种基于肝活检诊断非酒精性脂肪性肝炎的评分系统。
J Pathol Transl Med. 2020 May;54(3):228-236. doi: 10.4132/jptm.2020.03.07. Epub 2020 Apr 15.
6
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
7
Substantial Interobserver Agreement in the Diagnosis of Dysplasia in Barrett Esophagus Upon Review of a Patient's Entire Set of Biopsies.在对患者整套活检进行复查时,巴雷特食管中异型增生的诊断具有显著的观察者间一致性。
Am J Surg Pathol. 2018 Mar;42(3):376-381. doi: 10.1097/PAS.0000000000000988.
8
Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的组织病理学评估中的观察者间变异性。
Hepatol Res. 2005 Oct;33(2):122-7. doi: 10.1016/j.hepres.2005.09.018.
9
Nonalcoholic fatty liver disease: different classifications concordance and relationship between degrees of morphological features and spectrum of the disease.非酒精性脂肪性肝病:不同分类的一致性以及形态学特征程度与疾病谱之间的关系。
Anal Cell Pathol (Amst). 2014;2014:526979. doi: 10.1155/2014/526979. Epub 2014 Dec 2.
10
Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.2 型糖尿病患者非酒精性脂肪性肝病的组织病理学分期:患病率及相关因素。
Liver Int. 2011 May;31(5):700-6. doi: 10.1111/j.1478-3231.2011.02482.x. Epub 2011 Feb 20.

引用本文的文献

1
Chronic polypharmacy, monotherapy, and deprescribing: Understanding complex effects on the hepatic proteome of aging mice.慢性多重用药、单一疗法与撤药:理解对衰老小鼠肝脏蛋白质组的复杂影响。
Aging Cell. 2025 Jan;24(1):e14357. doi: 10.1111/acel.14357. Epub 2024 Oct 27.
2
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis.在 II 期临床试验中使用司美格鲁肽治疗非酒精性脂肪性肝炎,对肝活检进行人工智能评分。
Hepatology. 2024 Jul 1;80(1):173-185. doi: 10.1097/HEP.0000000000000723. Epub 2023 Dec 19.
3
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease.

本文引用的文献

1
Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research.非酒精性脂肪性肝病:临床研究中的病理模式和肝活检评估。
Semin Liver Dis. 2012 Feb;32(1):3-13. doi: 10.1055/s-0032-1306421. Epub 2012 Mar 13.
2
A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease.非酒精性脂肪性肝病治疗的随机试验的荟萃分析。
Hepatology. 2010 Jul;52(1):79-104. doi: 10.1002/hep.23623.
3
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.非酒精性脂肪性肝病与肝细胞癌:沉甸甸的关联。
代谢功能障碍相关脂肪性肝病的基因-表型多模态综合数据库。
Nat Med. 2023 Nov;29(11):2939-2953. doi: 10.1038/s41591-023-02602-2. Epub 2023 Oct 30.
4
Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.人工智能与深度学习:非酒精性脂肪性肝病/非酒精性脂肪性肝炎组织病理学诊断的新工具。
Comput Struct Biotechnol J. 2023 Mar 30;21:2495-2501. doi: 10.1016/j.csbj.2023.03.048. eCollection 2023.
5
CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease.基于 CT 的 Hounsfield 单位值反映了低级别脂肪肝患者肝脂肪变性的程度。
BMC Gastroenterol. 2023 Mar 17;23(1):77. doi: 10.1186/s12876-023-02717-3.
6
Non-alcoholic fatty liver disease: the pathologist's perspective.非酒精性脂肪性肝病:病理学家的视角。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S302-S318. doi: 10.3350/cmh.2022.0329. Epub 2022 Nov 15.
7
Improved pathology reporting in NAFLD/NASH for clinical trials.改善用于临床试验的非酒精性脂肪性肝病/非酒精性脂肪性肝炎的病理报告。
J Clin Pathol. 2022 Feb;75(2):73-75. doi: 10.1136/jclinpath-2021-207967. Epub 2021 Nov 9.
8
Deep learning quantification of percent steatosis in donor liver biopsy frozen sections.深度学习定量分析供体肝活检冷冻切片中的脂肪变性百分比。
EBioMedicine. 2020 Oct;60:103029. doi: 10.1016/j.ebiom.2020.103029. Epub 2020 Sep 24.
9
An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials.一种用于非酒精性脂肪性肝炎(NASH)临床试验精确筛选和入组的改进型qFibrosis算法
Diagnostics (Basel). 2020 Aug 28;10(9):643. doi: 10.3390/diagnostics10090643.
10
Discordant pathological diagnosis of non-alcoholic fatty liver disease: A prospective multicenter study.非酒精性脂肪性肝病的不一致病理诊断:一项前瞻性多中心研究。
JGH Open. 2019 Dec 17;4(3):497-502. doi: 10.1002/jgh3.12289. eCollection 2020 Jun.
Hepatology. 2010 May;51(5):1820-32. doi: 10.1002/hep.23594.
4
Pathology of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的病理学。
Nat Rev Gastroenterol Hepatol. 2010 Apr;7(4):195-203. doi: 10.1038/nrgastro.2010.21. Epub 2010 Mar 2.
5
Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study.儿童非酒精性脂肪性肝炎:一项多中心临床病理研究。
Hepatology. 2009 Oct;50(4):1113-20. doi: 10.1002/hep.23133.
6
Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.一项基于人群的队列研究中疑似非酒精性脂肪性肝病与死亡风险
Am J Gastroenterol. 2008 Sep;103(9):2263-71. doi: 10.1111/j.1572-0241.2008.02034.x. Epub 2008 Aug 5.
7
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的总体死亡率和肝脏相关死亡率升高。
J Hepatol. 2008 Oct;49(4):608-12. doi: 10.1016/j.jhep.2008.06.018. Epub 2008 Jul 9.
8
Pathology of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的病理学
Am J Clin Pathol. 2007 Nov;128(5):837-47. doi: 10.1309/RTPM1PY6YGBL2G2R.
9
Epidemiology and natural history of NAFLD and NASH.非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的流行病学及自然史
Clin Liver Dis. 2007 Feb;11(1):1-16, vii. doi: 10.1016/j.cld.2007.02.009.
10
Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.病态肥胖青少年非酒精性脂肪性肝病的组织学谱
Clin Gastroenterol Hepatol. 2006 Feb;4(2):226-32. doi: 10.1016/s1542-3565(05)00978-x.